Volpara Health Technologies Limited
VPAHF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 35% | 33.9% | 47.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 92.5% | 91.2% | 91.4% | 86% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -20.8% | -57.1% | -92% | -158.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -28% | -63% | -88.6% | -160.9% |
| EPS Diluted | -0.036 | -0.061 | -0.065 | -0.094 |
| % Growth | 40.1% | 6.3% | 31.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |